Christopher Koivisto to Mice, Knockout
This is a "connection" page, showing publications Christopher Koivisto has written about Mice, Knockout.
Connection Strength
0.172
-
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma. Neoplasia. 2020 10; 22(10):484-496.
Score: 0.126
-
Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma. J Clin Invest. 2017 Mar 01; 127(3):830-842.
Score: 0.025
-
Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles. Nat Cell Biol. 2015 Aug; 17(8):1036-48.
Score: 0.022